European Healthtech startup funding raised during September 2026.
In September 2026, 37 European Healthtech companies raised a combined €833M across 38 funding rounds, up 55.1% versus September 2025. UK led by capital raised, and European Investment Bank (EIB) was the most active investor. Data as of 1 Oct 2026.
1 exit.
| €78M |
| AnaCardio | Series B | Sep 2026 | €63M |
| Anaconda Biomed | Other | Sep 2026 | €49M |
| Aptadir Therapeutics | Seed | Sep 2026 | €40M |
| Implicity | Growth/Late | Sep 2026 | €35M |
| Ethris | Other | Sep 2026 | €30M |
| Biolevate | Series A | Sep 2026 | €30M |
| NovaGo Therapeutics | Series B | Sep 2026 | €26M |
| Neurent Medical | Other | Sep 2026 | €21M |
| Tensive | Debt | Sep 2026 | €20M |
| MMI | Series B | Sep 2026 | €17M |
| iPremom | Seed | Sep 2026 | €15M |
